Unveiling the role of KRAS in tumor immune microenvironment
Authors:
- Miao XuMXMiao Xu
- Ti WenTWTi Wen
- Xiujuan QuXQXiujuan Qu
Open Access
- 2 January 2024
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 171, 116058
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82272853)
- China Medical University (2022JH2/20200039)
This publication has 137 references indexed in Scilit:
- K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactionsNature, 2013
- Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal CancerNew England Journal of Medicine, 2013
- Differential Expression of IL-17, 22 and 23 in the Progression of Colorectal Cancer in Patients with K-ras Mutation: Ras Signal Inhibition and Crosstalk with GM-CSF and IFN-γPLOS ONE, 2013
- Prognostic value of K-RAS mutations in patients with non-small cell lung cancer: A systematic review with meta-analysisLung Cancer, 2013
- Prognostic and Predictive Value of KRAS Mutations in Advanced Non-Small Cell Lung CancerPLOS ONE, 2013
- Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical OutcomeJNCI: Journal of the National Cancer Institute, 2012
- KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studiesLung Cancer, 2010
- Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancerThe Lancet Oncology, 2008
- Identification of transforming gene in two human sarcoma cell lines as a new member of the ras gene family located on chromosome 1Nature, 1983
- Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.Proceedings of the National Academy of Sciences, 1982